Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive TrialsMax Kates, Trinity J. Bivalacqua, Marcus J. Daniels et al.|Clinical Cancer Research|2019Cited by 167
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E.N. Becker, Trinity J. Bivalacqua, Alexa Meyer et al.|European Urology|2020Cited by 72